RSS Feedhttps://biomed.staff.au.dk/en-gbFri, 01 May 2026 08:28:16 +0200Fri, 01 May 2026 08:28:16 +0200TYPO3 EXT:newsnews-29420Wed, 25 Mar 2026 13:06:39 +0100New research project to pave the way for treatment of Parkinsons diseasehttps://biomed.au.dk/display/artikel/new-research-project-to-pave-the-way-for-treatment-of-parkinsons-diseaseA new research project aims to develop a treatment that can remove and prevent the spread of a toxic protein in the brain that drives Parkinsons disease. Innovation Fund Denmark has invested DKK 26.7 million in the project.Parkinsons disease is the fastest-growing neurological disorder, and approximately 22,500 Danes are currently living with the condition. Existing treatments only alleviate symptoms and cannot slow disease progression, which gradually impairs patients movement and quality of life.

In the DESYNA project, researchers from the Department of Biomedicine, the Department of Clinical Medicine, and iNANO are collaborating with the biotech company Draupnir Bio to develop a new treatment that specifically degrades aggregates of the protein alpha-synuclein in the brain. These aggregates play a central role in the development of the disease and its spread between neurons.

The new approach combines advanced protein degradation technology with cutting-edge research in neurodegeneration. The goal is to halt disease progression by both removing harmful protein aggregates and preventing their spread.

This project places Denmark at the forefront of Parkinsons disease research and represents an ambitious strategy that offers hope to patients living with the disease, says Associate Professor Simon Glerup from the Department of Biomedicine and CSO at Draupnir Bio, who leads the project.

The project has received a Grand Solutions grant running over three years and aims to deliver new treatment candidates that can be further developed towards clinical testing.

The news is based on press material from Draupnir Bio.

Contact
Associate Professor and Chief Scientific Officer Simon Glerup
Aarhus University, Department of Biomedicine and Draupnir Bio
Phone: +45 51 22 17 27
Email: glerup@draupnir.bio

]]>HealthPublic/MediaStaffDepartment of BiomedicineSebastian Alexander Skousgaard17744403991774440399news-29126Thu, 19 Feb 2026 10:11:56 +0100Do you want to talk to Nature editors? Then invite them to LEGOLANDhttps://health.au.dk/en/display/artikel/do-you-want-to-talk-to-nature-editors-then-invite-them-to-legolandTwo intense days in Billund gave researchers from the Department of Biomedicine direct access to editors from some of the worlds most influential journals.HealthDepartment of BiomedicinePublic/MediaStaffHealthDepartment of BiomedicineCarl Ingemann Hedegaard17714923161771492316news-28651Thu, 04 Dec 2025 11:45:17 +0100Here are the 13 new Honorary Skou Professorshttps://biomed.au.dk/display/artikel/here-are-the-13-new-honorary-skou-professorsHealth is appointing 13 new international top researchers as special adjunct professors. They are all receiving the title of Honorary Skou Professor and will help strengthen the facultys profile as an international research and educational institution.ResearchPublic/MediaStaffHealthDepartment of BiomedicineDepartment of Clinical MedicineDepartment of Forensic MedicineDepartment of Public HealthIOOSLise Wendel Eriksen17648451171764845117